Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
8.78
+0.65 (8.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $296.52 million as of December 20, 2024. Its market cap has increased by 87.38% in one year.
Market Cap
296.52M
Enterprise Value
223.28M
1-Year Change
87.38%
Ranking
Category
Stock Price
$8.78
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $296.52M, a decrease of -39.25%. That is a compound annual growth rate of -13.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 296.52M | 58.24% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OraSure Technologies | 282.71M |
| Benitec Biopharma | 282.54M |
| Foghorn Therapeutics | 276.85M |
| Sanara MedTech | 276.13M |
| Procaps Group | 275.29M |
| C4 Therapeutics | 271.41M |
| Vanda Pharmaceuticals | 269.97M |
| Amylyx Pharmaceuticals | 269.61M |